FDA Announces Label Change to Nizoral Warning of Risk of Liver and Adrenal Injury
In late July 2013, Americans were notified of a Nizoral label change to warn of liver injury risk. The notification was issued by the FDA due to the drug’s inherent risks. The drug, which is classified as an anti-fungal and comes in several forms, has been in use for some time now. At this time, […]
